CDMRP Pancreatic Cancer Research Program Idea Development Award

The mission of the PCARP is to promote rigorous, innovative, high-impact research that leads to new pancreatic cancer diagnostic and therapeutic tools through collaboration.

• Understanding precursors, origins, and early progression of pancreatic cancer
• Understanding the events that promote pancreatic cancer metastasis
• Understanding the relationship between oncogenic signaling and the tumor microenvironment that drives drug resistance and therapeutic response
• Integration of biologic and imaging biomarkers to drive more precise and earlier detection and prognosis
• Defining viable tumor burden
• Supportive care and patient-reported outcomes, quality of life, and perspectives during treatment and survivorship
• New drug development targeted toward cancer sensitivity and resistance mechanisms including immune mechanisms of resistance
• Development of pharmacological, immunological, or genetic interception approaches

Funding: $500,000 total (Partnering Option for Early-Career Investigator $650,000)

Duration: 3 years 

Research Authority due date: 17.8.20

Pre application (required) due date: 25.8.20

Full proposal due date: 20.11.20